ama1
Vaccineexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2005 (NCT00114010)
Timeline
2000s
- Jan 1, 2005
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Plasmodium falciparumImmunity, active
Plasmodium falciparum immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ama1
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01739036 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2013 | University of Oxford |
| NCT00431808 | Phase 1 | May 1, 2007 | African Malaria Network Trust |
| NCT00114010 | Phase 1 | Apr 1, 2005 | National Institute of Allergy and Infectious Diseases (NIAID) |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| African Malaria Network Trust | Academic/Hospital | 1 | 1 | 1 | 2007 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 1 | 1 | 1 | 2005 |
| University of Oxford | Academic/Hospital | 1 | 1 | 1 | 2013 |
3 organizations
Page 1 / 1